Your browser doesn't support javascript.
loading
Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia.
Kättström, Magdalena; Uggla, Bertil; Tina, Elisabet; Kimby, Eva; Norén, Torbjörn; Athlin, Simon.
Afiliação
  • Kättström M; Section of Hematology, Department of Medicine, Faculty of Medicine and Health, Örebro University, SE 70185 Örebro, Sweden. Electronic address: Magdalena.kattstrom@regionorebrolan.se.
  • Uggla B; Section of Hematology, Department of Medicine, Faculty of Medicine and Health, Örebro University, SE 70185 Örebro, Sweden.
  • Tina E; Department of Clinical Research Laboratory, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Kimby E; Unit of Hematology, Department of Medicine, Karolinska Institute, Stockholm, Sweden.
  • Norén T; Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Athlin S; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, SE 70185 Örebro, Sweden.
Vaccine ; 41(19): 3128-3136, 2023 05 05.
Article em En | MEDLINE | ID: mdl-37061372

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Leucemia Linfocítica Crônica de Células B Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Leucemia Linfocítica Crônica de Células B Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article